CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 8-K Event Material agreement
- DEF 14A Proxy Proxy Statement
- 4 Option exercise Director acquired 68,635 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 34,830 shares (to pay taxes)
- EFFECT Other Notice of Effectiveness
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Option exercise CEO, Chairman of the Board acquired 39,637 shares (option exercise)
- 4 Open-market buy Director bought 50,000 shares at an average $3.73 ($186,729)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
Page 29 of 62 · 1,225 filings